|Articles|October 14, 2009
Emerging Leaderhip Pharma Awards- Frank Karbe
Advertisement
Frank Karbe,
Chief Financial Officer,
Exelixis
Download Adobe Flash Player
Frank Karbe, executive vice president and chief financial officer of Exelixis, reflects on some of the financial, regulatory, and intellectual property challenges facing the biopharma industry and shares his thoughts on what emerging leaders will need to do to address them.Listen to the Podcast for more coverage.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5